Search results
Results from the WOW.Com Content Network
Eflornithine. Eflornithine, sold under the brand name Vaniqa among others, is a medication used to treat African trypanosomiasis (sleeping sickness) and excessive hair growth on the face in women. [1][3][4] Specifically it is used for the second stage of sleeping sickness caused by T. b. gambiense and may be used with nifurtimox. [3][5] It is ...
Prescription medications: Dr. Hart says there are topical and oral prescription medications that can slow down facial hair growth, including spironolactone, a medication typically prescribed to ...
A treatment regimen known as nifurtimox-eflornithine combination treatment (NECT) is used in second stage gambiense African trypanosomiasis throughout Africa where the disease is endemic. [4] The regimen involves slow infusion of 400 mg of eflornithine every 12 hours for 7 days combined with 15 mg/kg of nifurtimox orally three times a day for ...
Eflornithine irreversible inhibits ornithine decarboxylase which is an important enzyme involved in hair growth. [5] Elfornithine does not remove hair through epilation or depilation but rather slows hair growths. Some side effects of eflornithine cream include acne, folliculitis, stinging or burning, skin irritation, redness, itching, and ...
As estrogen levels drop during menopause, collagen production decreases, contributing to the development of lines, wrinkles and sagging skin. Topical estrogen cream can reach the deeper layer of ...
Yet no one knows precisely what causes it, and it has no cure. PCOS is a common reason why women have difficulty getting pregnant or have complications during pregnancy. This condition is also ...
Polycystic ovary syndrome, or polycystic ovarian syndrome (PCOS), is the most common endocrine disorder in women of reproductive age. [14] The syndrome is named after cysts which form on the ovaries of some women with this condition, though this is not a universal symptom, and not the underlying cause of the disorder.
However, I do agree with you that the dual faceted aspect of Eflornithine needs to be more clear, either by dividing this article into 2, or creating a different article focusing on the topical form of Eflornithine and this article focusing on its internal use. --78.86.159.199 21:07, 22 August 2008 (UTC)